CSIMarket
 


Kempharm Inc  (KMPH)
Other Ticker:  
 
 

KMPH's Capital Expenditures Growth by Quarter and Year

Kempharm Inc's Capital Expenditures results by quarter and year




KMPH Capital Expenditures (in millions $) FY 2022 FY 2021 FY 2020 FY 2019
IV Quarter December - 0.02 0.03 0.01
III Quarter September -0.03 0.00 0.00 0.00
II Quarter June 0.02 0.08 0.00 0.00
I Quarter March 0.02 0.00 0.01 0.02
FY   0.01 0.10 0.04 0.03



KMPH Capital Expenditures third quarter 2022 Y/Y Growth Comment
Kempharm Inc in the third quarter 2022 recorded Capital Expenditures of $ -0.03 millions.

Looking into third quarter 2022 results within Major Pharmaceutical Preparations industry 216 other companies have achieved higher Capital Expenditures growth. While Kempharm Inc' s Capital Expenditures no change of % ranks overall at the positon no. 2657 in the third quarter 2022.




KMPH Capital Expenditures ( Y/Y Growth %) 2022
2021 2020 2019
IV Quarter December - -33.33 % 200 % -50 %
III Quarter September - - - -
II Quarter June -75 % - - -
I Quarter March - - -50 % -
FY   - 150 % 33.33 % 0 %

Financial Statements
Kempharm Inc's third quarter 2022 Capital Expenditures $ -0.03 millions KMPH's Income Statement
Kempharm Inc's third quarter 2021 Capital Expenditures $ 0.00 millions Quarterly KMPH's Income Statement
New: More KMPH's historic Capital Expenditures Growth >>


KMPH Capital Expenditures (Quarter on Quarter Growth %)

2022
2021 2020 2019
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June 0 % - - -
I Quarter March 0 % - 0 % 0 %
FY (Year on Year)   - 150 % 33.33 % 0 %




Capital Expenditures third quarter 2022 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #217
Healthcare Sector #564
Overall #2657

Capital Expenditures Y/Y Growth Statistics
High Average Low
-55.93 % -61.62 % -67.31 %
(Jun 30 2022)   (Sep 30 2022)
Capital Expenditures third quarter 2022 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #217
Healthcare Sector #564
Overall #2657
Capital Expenditures Y/Y Growth Statistics
High Average Low
-55.93 % -61.62 % -67.31 %
(Jun 30 2022)   (Sep 30 2022)

Capital Expenditures by Quarter for the Fiscal Years 2019, 2020, 2021, 2022

Kempharm Inc's Q/Q Capital Expenditures Growth


Capital Expenditures Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


KMPH's III. Quarter Q/Q Capital Expenditures Comment
Recent accomplishment of -0.03 millions by Kempharm Inc look even worse if you take a look at 0.02 millions in the previous quarter.

Within Major Pharmaceutical Preparations industry Kempharm Inc achieved highest sequential Capital Expenditures growth. While Kempharm Inc's Capital Expenditures growth quarter on quarter, overall rank is .


Capital Expenditures Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Capital Expenditures Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Capital Expenditures Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


KMPH's III. Quarter Q/Q Capital Expenditures Comment
III. Quarter 2022 accomplishment of -0.03 millions by Kempharm Inc look even worse if you take a look at 0.02 millions in the second quarter.

Within Major Pharmaceutical Preparations industry Kempharm Inc achieved highest sequential Capital Expenditures growth. While Kempharm Inc's Capital Expenditures growth quarter on quarter, overall rank is .


Kempharm Inc's 12 Months Capital Expenditures Growth Year on Year


Capital Expenditures TTM Growth

12 Months Ending
(Sep 30 2022)
12 Months Ending
(Jun 30 2022)
12 Months Ending
(Mar 31 2022)
12 Months Ending
(Dec 31 2021)
12 Months Ending
(Sep 30 2021)
Cumulative Capital Expenditures 12 Months Ending $ 0.02 $ 0.05 $ 0.12 $ 0.00 $ 0.00
Y / Y Capital Expenditures Growth (TTM) - - - - -
Year on Year Capital Expenditures Growth Overall Ranking # # # # #
Seqeuential Capital Expenditures Change (TTM) -67.31 % -55.93 % - - -
Seq. Capital Expenditures Growth (TTM) Overall Ranking # 2657 # 2811 # 0 # 0 # 0




Cumulative Capital Expenditures growth Comment


Kempharm Inc achieved highest trailing twelve month year on year Capital Expenditures growth. While overall Capital Expenditures growth ranking, remained unchanged compare to the previous quarter at no. .

Capital Expenditures TTM Q/Q Growth Statistics
High Average Low
-55.93 %
-61.62 %
-67.31 %
 

Capital Expenditures TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall # 0

Capital Expenditures TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Capital Expenditures TTM Q/Q Growth Company Ranking
Within: No.
Industry # 217
Sector # 564
S&P 500 # 2657
Cumulative Capital Expenditures growth Comment


Kempharm Inc achieved highest trailing twelve month year on year Capital Expenditures growth. While overall Capital Expenditures growth ranking, remained unchanged compare to the previous quarter at no. .

Capital Expenditures TTM Q/Q Growth Statistics
High Average Low
-55.93 %
-61.62 %
-67.31 %
 


Capital Expenditures TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall # 0

Capital Expenditures TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Capital Expenditures TTM Q/Q Growth Company Ranking
Within: No.
Industry # 217
Sector # 564
S&P 500 # 2657




Other Capital Expenditures Growth
Major Pharmaceutical Preparations Industry Capital Expenditures Growth Trends and Statistics
Healthcare Sector Capital Expenditures Growth Statistics
Capital Expenditures Growth Trends for overall market
KMPH's Capital Expenditures Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Capital Expenditures Growth
Lowest Ranking Capital Expenditures Growth
Capital Expenditures Growth for KMPH's Competitors
Capital Expenditures Growth for Kempharm Inc's Suppliers
Capital Expenditures Growth for KMPH's Customers

You may also want to know
KMPH's Annual Growth Rates KMPH's Profitability Ratios KMPH's Asset Turnover Ratio KMPH's Dividend Growth
KMPH's Roe KMPH's Valuation Ratios KMPH's Financial Strength Ratios KMPH's Dividend Payout Ratio
KMPH's Roa KMPH's Inventory Turnover Ratio KMPH's Growth Rates KMPH's Dividend Comparisons



Companies with similar Capital Expenditures no change for the quarter ending Sep 30 2022 within Healthcare SectorY/Y Change %Capital Expenditures for the quarter ending Sep 30 2022
Tela Bio Inc -0.34%$ -0.344 millions
Edwards Lifesciences Corporation-1.32%$ -1.318 millions
Guardant Health Inc -1.91%$ -1.910 millions
Seagen Inc -2.56%$ -2.556 millions
Addus Homecare Corporation-3.00%$ -2.999 millions
Concert Pharmaceuticals Inc -3.03%$ -3.030 millions
Merck and Co Inc -3.92%$ -3.925 millions
Precision Optics Corporation Inc -3.93%$ -3.925 millions
Nextcure Inc -4.32%$ -4.317 millions
Cvs Health Corporation-4.61%$ -4.605 millions
Electromed inc -5.19%$ -5.185 millions
Sight Sciences Inc -5.23%$ -5.226 millions
Veracyte Inc -5.41%$ -5.408 millions
Baxter International Inc -6.15%$ -6.145 millions
Natera Inc -7.06%$ -7.057 millions
Sio Gene Therapies Inc -7.14%$ -7.143 millions
Replimune Group Inc -7.48%$ -7.477 millions
Rockwell Medical inc -7.87%$ -7.874 millions
Harvard Bioscience Inc-7.92%$ -7.917 millions
Bristol myers Squibb Company-8.52%$ -8.519 millions
Davita Inc -8.54%$ -8.535 millions
Dentsply Sirona Inc -8.57%$ -8.571 millions
Sunlink Health Systems Inc -9.83%$ -9.827 millions
Moderna Inc -10.10%$ -10.101 millions
Te Connectivity Ltd -10.17%$ -10.169 millions
Rhythm Pharmaceuticals inc -10.38%$ -10.377 millions
Sarepta Therapeutics Inc -10.93%$ -10.930 millions
West Pharmaceutical Services Inc -11.49%$ -11.485 millions
Recursion Pharmaceuticals Inc -11.78%$ -11.776 millions
Cytek Biosciences Inc -12.08%$ -12.080 millions


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

AVXL's Profile

Stock Price

AVXL's Financials

Business Description

Fundamentals

Charts & Quotes

AVXL's News

Suppliers

AVXL's Competitors

Customers & Markets

Economic Indicators

AVXL's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071